GILD

Gilead SciencesC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

m&a

Source

External coverage

Decided

2026-06-23

Gilead Sciences to acquire Ouro Medicines, expanding autoimmune therapy portfolio

Gilead announced an acquisition of Ouro Medicines to expand its autoimmune therapy portfolio, a modestly positive strategic read-through for Gilead, but the artifact is thin on price, financing, and expected earnings impact.

View event details

Sentiment decomposition

+52.1

30-day score

Company-55%

Macro-30%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for GILD. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-06-23 • Updated scheduledSource: News desk